Company News in the Life Science Industry

»

Reset 

ALX Oncology Added to Russell 2000® and 3000® Indexes

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  ALX Oncology, Inc.

Axsome Therapeutics Announces AXS-07 Phase 3 Migraine Trial Results Selected by the American Academy of Neurology Science Committee as Featured Presentation

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Axsome Therapeutics, Inc.

Amunix to Present Preclinical Data on Protease-Activated HER2- and EGFR-Targeted T Cell Engagers at ESMO Virtual Congress 2020

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Amunix Pharmaceuticals, Inc.

Microbix Announces Extension of Warrant Expiry Dates

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Microbix Biosystems Inc.

Applied Therapeutics to Present Data on AT-001 for Treatment of Diabetic Cardiomyopathy at 56th Annual Meeting of the European Association for the Study of Diabetes

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Applied Therapeutics, Inc.

OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2020

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Oxford BioMedica plc

Summit Therapeutics Announces U.K. Court Approval of Scheme

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Summit Therapeutics plc

Aravive Appoints Michael W. Rogers to Board of Directors

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Aravive, Inc

Mindleap Health Implements HIPAA Compliance Standards and Appoints Former Canadian Ministry of Health Telemedicine Expert as Head of Program Management

Read more ››
By: GlobenewsWire - 17 Sep 2020

Cytokinetics Announces GALACTIC-HF Accepted for Presentation In Late Breaking Clinical Trial Session At American Heart Association Scientific Sessions

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Cytokinetics, Inc.

BetterLife Scales up Manufacturing of AP-003 (Interferon Alpha 2b) to Prepare for Clinical Trials

Read more ››
By: GlobenewsWire - 17 Sep 2020

InflaRx Announces Leadership Team Additions with New CFO and Newly Created Position of Chief Strategy Officer

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  InflaRx N.V.

Tabula Rasa HealthCare Supports Legislation Establishing Medication Risk Prevention Program for NJ Medicaid

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Tabula Rasa HealthCare

XWPharma Announces $40 Million Financing and Appoints Leonard Blum as Chief Executive Officer

Read more ››
By: GlobenewsWire - 17 Sep 2020

ORYZON Presents Efficacy and Safety Results of its CLEPSIDRA Trial with Iadademstat in ED-SCLC Patients at ESMO-2020

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Oryzon Genomics, S.A. | Oryzon Genomics

Tauriga Sciences Announces 40% Reduction in Tauri-Gum Production Costs in Support of its Nationwide Launch and Expanded Production

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Tauriga Sciences, Inc.

Avadel to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Avadel Pharmaceuticals plc

Cue Biopharma Welcomes Tamar Howson to its Board of Directors

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Cue Biopharma, Inc.

AgraFlora’s Subsidiary Farmako Obtains Additional EU-GMP Cannabis for Distribution in Germany

Read more ››
By: GlobenewsWire - 17 Sep 2020

Vaccinex Announces Clinical Collaboration with Merck to Evaluate Pepinemab in Combination with KEYTRUDA® in Advanced, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Read more ››
By: GlobenewsWire - 17 Sep 2020
Related companies:  Vaccinex, Inc
«  1  2  3  4  5  6  7  8 9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies